Share on LinkedInShare on LinkedIn

ARTICLE · 15 OCTOBER 2019

CDSCO Alerts On Medtronic Insulin Pumps For Having Potential Cybersecurity Risk

S&A Law Offices
S&A Law Offices
Contributor
S&A Law Offices

S&A Law Offices

S&A Law Offices is a full-service law firm headquartered in Delhi NCR. The firm has 300+...

View firm profile
Explore more from S&A Law Offices

On July 2, 2019, Central Drug Standard Control Organization (CDSCO) issued an alert for insulin pumps manufactured by Medtronic for its potential cybersecurity risk which can be a serious health...

IndiaTechnology

On July 2, 2019, Central Drug Standard Control Organization (CDSCO) issued an alert for insulin pumps manufactured by Medtronic for its potential cybersecurity risk which can be a serious health hazard for the patient, as the insulin pump can be accessed and controlled by another person by compromising the cybersecurity.

Background of Cybersecurity Risk

The CDSCO alert is followed by the United States Food and Drug Administration (US FDA) warning letter, which said that certain Medtronic MiniMed insulin pumps are being withdrawn from market due to potential cybersecurity risks. However, no such reports of unauthorized persons changing settings or controlling insulin delivery has been confirmed. Now the alert issued by CDSCO clearly describes the risks associated with the use of the device. According to the CDSCO alert cybersecurity risk allows an unauthorized person with special technical skills to connect to a nearby insulin pump wirelessly, and then take control

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from